- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01833871
The Use of Doppler to Diagnose Myometrial Masses (3D)
April 15, 2013 updated by: Eman Elkattan, Cairo University
Uterine Artery Doppler and Three Dimensional Power Doppler in the Diagnosis of Myometrial Masses
Colour Doppler sonography has also been evaluated in differentiating adenomyosis from fibroids.
Two dimensional color Doppler ultrasound revealed that 87% of adenomyosis cases had vessel distributions different from those found in leiomyoma cases, in addition to a high pulsatility index (PI) .Adenomyotic lesions had randomly scattered vessels or intratumoral signals while leiomyomas usually had peripheral scattered or outer feeding vessels.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Because it is more sensitive, less angle-dependent, and not susceptible to aliasing , power Doppler Sonography has the potential to detect fluctuations in blood flow , with results superior to those of frequency-based color Doppler sonography, particularly in situations of low-velocity blood flow.
Three dimensional power Doppler ultrasonography can be applied to differentiate between uterine adenomyosis and leiomyoma ,and it may reduce the number of false positives by detailed investigations.
Study Type
Interventional
Enrollment (Anticipated)
120
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt
- Recruiting
- Cairo University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Age between 20 & 60 years.
- Asymptomatic pts which discover the mass accidentally .
- Patients with symptoms like menorrhagia, menometrorrhagia, dysmenorrheal , abdominal masses.
- Patients scheduled for hysterectomy(abdominal/vaginal or Laparoscopic)
- Patients scheduled for myomectomy.
Exclusion Criteria:
- Pregnant patients
- Age over 60 or under 20years.
- Conservative management (Non surgical)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: myometrial fibroid/adenomyoma
Patients scheduled for myomectomy or hysterectomy with preoperative diagnosis of uterine myoma, adenomyosis or both by ultrasound .Trans-vaginal 3D power Doppler and uterine artery doppler will be done for all participants prior to surgery.
|
Trans-vaginal 3D power Doppler Ultrasonographic examination will be done for all participants prior to surgery.
The ultrasonographic examination will provide data related to lesion size, lesion volume, vascular location (location), vascular index (VI), flow index (FI), and vascular-flow index (VFI).
The region of interest will include the entire region of the uterine mass.
The virtual organ computer aided analysis (VOCAL) software for the analysis of 3D power Doppler histograms will be used with computer algorithms to form indices of blood flow and vascularization.
All data will be collected and compared with the post operative histopathology results.
uterine artery Doppler indices(RI,PI) are measured for all cases with myometrial mass
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Power Doppler Vascular indices
Time Frame: 9 months
|
The ultrasonographic examination will provide data related to lesion size, lesion volume, uterine artery doppler indices and vascular location (location), vascular index (VI), flow index (FI), and vascular-flow index (VFI).
The region of interest will include the entire region of the uterine mass.
The virtual organ computer aided analysis (VOCAL) software for the analysis of 3D power Doppler histograms will be used with computer algorithms to form indices of blood flow and vascularization.
All data will be collected and compared with the post operative histopathology results.
|
9 months
|
|
Uterine artery doppler indices in fibroids in relation to adenomyosis
Time Frame: 9 months
|
Uterine artery doppler indices(RI,PI) in fibroids in relation to adenomyosis
|
9 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2013
Primary Completion (Anticipated)
October 1, 2013
Study Completion (Anticipated)
December 1, 2013
Study Registration Dates
First Submitted
April 4, 2013
First Submitted That Met QC Criteria
April 15, 2013
First Posted (Estimate)
April 17, 2013
Study Record Updates
Last Update Posted (Estimate)
April 17, 2013
Last Update Submitted That Met QC Criteria
April 15, 2013
Last Verified
April 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- Protocol200
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Uterine Masses
-
Mahidol UniversityRecruiting
-
Peking Union Medical College HospitalCompletedPancreatic Masses
-
American Society for Gastrointestinal EndoscopyMidwest Biomedical Research FoundationUnknownMediastinal or Intra-abdominal Lymphadenopathy, | Pancreatic Masses, | Left Adrenal Masses, | Gastrointestinal Submucosal Lesions, and | Liver MassesUnited States
-
Assiut UniversityNot yet recruiting
-
University Health Network, TorontoWithdrawn
-
Brugmann University HospitalCompletedAdnexal MassesBelgium
-
Asan Medical CenterCompletedPancreatic MassesKorea, Republic of
-
Shandong UniversityUnknownSolid Pancreatic MassesChina
-
The Third Xiangya Hospital of Central South UniversityUnknownSolid Pancreatic MassesChina
-
Assiut UniversityNot yet recruiting
Clinical Trials on Three dimensional Power Doppler to the myometrial mass
-
Ain Shams UniversityCompletedPolycystic Ovary Syndrome | Infertility, FemaleEgypt